Teva Pharm Q3 profit misses estimates, sees recovery into Q4 | Reuters
Teva share price jumps 55% in past three weeks - Globes
Teva Stock Upgraded After Earnings: What You Need to Know
Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
Sell Teva Pharmaceutical due to increasing generic drugs competition: Credit Suisse
Teva Pharmaceutical Industries Limited Stock Still Is a Deep Value Play | InvestorPlace
TEVA Price Target 2022 | Teva Pharmaceutical Industries Analyst Ratings
UBS raises Teva price target - Globes
Allergan, Teva and others start 2018 with price hikes: analyst | Fierce Pharma
Brokerages have given Teva Pharmaceutical Industries Limited (NYSE:TEVA) a consensus rating of "Hold." - Best Stocks
Teva Earnings Q3 2018 | AlphaStreet
Teva's CEO Shows He Means Business With Planned 25% Job Cuts - Bloomberg
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Analysts see upside in Teva share price - Globes
UBS raises Teva price target - Globes
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : TEVA Stock Price | IL0006290147 | MarketScreener
Definitive Proxy Statement
Teva Flip Flops Mush : Target
Is Teva Pharma's Restructuring Plan Actually 'More Reasonable'? | Investor's Business Daily
Teva Pharmaceutical (TEVA)
Teva down as it reports lower sales and profit for 2018
Teva Pharmaceutical Industries Ltd's (ADR) (TEVA) GmbH and Alder BioPharmaceuticals Form Global License Agreement
Teva Pharmaceutical Industries Reaches Analyst Target Price | Nasdaq
Teva Putting Its Troubles Behind, Why The Stock Is Cheap And I'm Long (NYSE: TEVA) | Seeking Alpha
Why Teva Pharmaceuticals Stock Has Two A-Products In The Bag (NYSE:TEVA) | Seeking Alpha
Settling a post-buyout hangover, Allergan gives Teva a $700M remedy | Fierce Pharma
